Ropes & Gray advised EQRx on the deal. EQRx announced a strategic drug discovery and development partnership to use Absci’s artificial intelligence and synthetic biology platform...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
